Maria Pavlaki

Dr. Maria Pavlaki

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
LBLamprini Banou
Lamprini Banou
ZTZoi Tsani
Zoi Tsani
KAKonstantinos Arvanitogiannis
Konstantinos Arvanitogiannis
MPMaria Pavlaki
Maria Pavlaki
ADAnna Dastiridou
Anna Dastiridou
SASofia Androudi
Sofia Androudi
Uveal melanoma represents the most prevalent form of primary malignant intraocular tumor in adults. Historically, enucleation was considered the gold-standard approach in the treatment of uveal melanoma. Currently, radiotherapy is the most commonly used therapy, aiming at a better quality of life. However, radiotherapy can result in several ocular complications, some of which may be vision-threatening. Radiation-induced dry eye, scleral necrosis, cataract, rubeosis iridis, neovascular glaucoma, radiation retinopathy, maculopathy, and optic neuropathy are the most common complications. This article aims to summarize the current literature regarding the ocular complications after radiotherapy, as well as their clinical features, risk factors, and management strategies. A thorough understanding of these issues is crucial for ophthalmologists and oncologists to provide optimal patient care, improve visual outcomes, and minimize long-term complications.

2 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
LBLamprini Banou
Lamprini Banou
ZTZoi Tsani
Zoi Tsani
KAKonstantinos Arvanitogiannis
Konstantinos Arvanitogiannis
MPMaria Pavlaki
Maria Pavlaki
ADAnna Dastiridou
Anna Dastiridou
SASofia Androudi
Sofia Androudi
Uveal melanoma represents the most prevalent form of primary malignant intraocular tumor in adults. Historically, enucleation was considered the gold-standard approach in the treatment of uveal melanoma. Nowadays, radiotherapy is the most commonly used therapy, aiming at a better quality of life. However, radiotherapy can result in several ocular complications, some of which may be vision-threatening. Radiation-induced dry eye, scleral necrosis, cataract, rubeosis iridis, neovascular glaucoma, radiation retinopathy and maculopathy and optic neuropathy are the most common. This article aims to summarize the current literature on the ocular complications after radiotherapy, their clinical features, risk factors and management strategies. A thorough understanding is crucial for ophthalmologists and oncologists to provide optimal patient care, improve visual outcomes, and minimize long-term complications.